Drug-resistant Candida auris fungus now confirmed in 23 U.S. states

Recent CDC surveillance confirms that the drug-resistant fungus Candida auris has been detected in 23 U.S. states, marking a resurgence of the organism first identified domestically in 2016. The fungus, often termed a "superbug" because of its resistance to common antifungal medications, typically does not cause illness in healthy people but can be fatal for hospitalized patients with compromised immunity. It can persist on surfaces for extended periods and reach patients through devices such as catheters, breathing tubes, and IV lines.

This year, nearly half of all states have reported cases, with Texas accounting for more than 700 infections and Michigan reporting 503, the two states with the highest numbers. Health officials stress that the pathogen’s ability to survive on equipment and resist treatment poses a growing challenge for infection-control programs nationwide. Ongoing monitoring and stricter hygiene protocols are being urged to curb further spread.